Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q3 2025 Earnings Call Transcript November 6, 2025
Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.07 EPS, expectations were $0.16.
Operator: Good afternoon, and welcome to the Eton Pharmaceuticals Third Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company’s request. At this time, I’d like to turn it over to David Krempa, Chief Business...
